Longboard Pharmaceuticals

Q: Where is Longboard Pharmaceuticals located?

Longboard Pharmaceuticals's headquarters are located at 4275 Executive Sq Ste 950, La Jolla, California, 92037, United States

Q: What is Longboard Pharmaceuticals's phone number?

Longboard Pharmaceuticals's phone number is (858) 789-9283

Q: What is Longboard Pharmaceuticals's stock symbol?

Longboard Pharmaceuticals's stock symbol is LBPH

Q: What is Longboard Pharmaceuticals's official website?

Longboard Pharmaceuticals's official website is www.longboardpharma.com

Q: What is Longboard Pharmaceuticals's Revenue?

Longboard Pharmaceuticals's revenue is $10.6 Million

Q: What is Longboard Pharmaceuticals's SIC code?

Longboard Pharmaceuticals's SIC: 87,873

Q: What is Longboard Pharmaceuticals's NAICS code?

Longboard Pharmaceuticals's NAICS: 54,541

Q: How many employees does Longboard Pharmaceuticals have?

Longboard Pharmaceuticals has 50 employees

Q: What industry does Longboard Pharmaceuticals belong to?

Longboard Pharmaceuticals is in the industry of: Business Services General , Business Services

Q: What is Longboard Pharmaceuticals competition?

Longboard Pharmaceuticals top competitors include: CANbridge Pharmaceuticals , Orphan Star Therapeutics , La Jolla Pharmaceutical , True North Therapeutics

Business Services · California, United States · 50 Employees

View Company Info for Free

About

Headquarters

4275 Executive Sq Ste 950, La Jolla, California...

Phone Number

(858) 789-9283

Website

www.longboardpharma.com

Revenue

$10.6 Million

Stock Symbol

LBPH

Industry

Business Services General

Business Services

Most Recent Scoops

Oct 16 2024

Mergers & Acquisitions (M&A)

Jul 17 2024

Earnings

Longboard Pharmaceuticals has recently announced 2024 Q1 report with the following insight: Ongoing pandemic, inflationary and political risks creating market instability.

See all scoops

Who is Longboard Pharmaceuticals

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel and transformative medicines for neurological diseases. The company develops bexicaserin (LP352), which has completed Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. It also develops LP659, an S1P receptor modulator for the treatment of neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.Explore more

Is this data correct?

View contact profiles from Longboard Pharmaceuticals

Popular SearchesLongboard Pharmaceuticals IncLongboard PharmaceuticalsSIC Code 87,873NAICS Code 54,541Ticker NASDAQ: LBPHShow more

Longboard Pharmaceuticals Org Chart

Kevin Lind

President, Chief Executive Officer & Director

Phone

Randall Kaye

Chief Medical Officer

Phone

Is Longboard Pharmaceuticals your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Website visits: Recent activity has been detected on your website

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Product Launch: Get notified when Longboard Pharmaceuticals launches new products

Funding: Get notified immidiatlly once Longboard Pharmaceuticals has new funding data

Earning: See what the market has to say on Longboard Pharmaceuticals recently announced quarterly report

Click to see if Longboard Pharmaceuticals had a recent Job posting/layoffs

Check out if Longboard Pharmaceuticals is spiking on competitors!

Check if Longboard Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!

Congratulate Masked Content for being promoted to Masked Content at Longboard Pharmaceuticals

Longboard Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic

Recommended Actions

Find VP level buyers at Longboard Pharmaceuticals

Find 3 more new buyers

Compare Similar Companies to Longboard Pharmaceuticals

Compare insights from companies similar to Longboard Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Longboard Pharmaceuticals

$10.6M

La Jolla Pharmaceutical

$52M

CANbridge Pharmaceuticals

$13.2M

100

Synageva BioPharma

$6.9M

True North Therapeutics

$5.6M

Orphazyme

$5.2M

Orphan Star Therapeutics

<$5M

View Email Formats for Longboard Pharmaceuticals

Longboard Pharmaceuticals Employee Growth Rate

Graph showing projected employee growth data for Longboard Pharmaceuticals

View Longboard Pharmaceuticals’s full employee growth data

Percentage of growth

1st year Mask

2nd year Mask

Longboard Pharmaceuticals Tech Stack

A closer look at the technologies used by Longboard Pharmaceuticals

PHP

See more technologies

Most Recent Scoops

Oct 16 2024

Mergers & Acquisitions (M&A)

Mergers & Acquisitions, Acquisitions, Mergers

Jul 17 2024

Earnings

Organizational Development

Jul 17 2024

Earnings

Longboard Pharmaceuticals has recently announced 2024 Q1 report with the following insight: Ongoing pandemic, inflationary and political risks creating market instability.

Jul 17 2024

Earnings

Longboard Pharmaceuticals has recently announced 2024 Q1 report with the following insight: Potential emergence of new treatment modalities like gene therapy.

New Hire, Demand Generation, General Counsel, Lead Generation

Jul 17 2024

Earnings

Longboard Pharmaceuticals has recently announced 2024 Q1 report with the following insight: Seasoned leadership team with drug discovery, development and commercialization expertise.

Application Development, Product Development, Research & Development, Sales, Learning & Development, Business Development, Sales Development, Customer Retention & Development, Organizational Development

See more scoops

Longboard Pharmaceuticals News & Media

Lundbeck announces expiration of Longboard tender offer and that all tender offer conditions are fulfilled
· A significant step forward in Lundbeck’s Focused Innovator strategy and advancing the goal of building a robust neuro-rare franchise · The transaction is expected to close on December 2, 2024, following Lundbeck’s acceptance of all shares of common stock validly tendered and not validly withdrawn pursuant to the tender offer · Total transaction value of approximately USD 2.6 billion equity value and USD 2.5 billion net of cash (approximately DKK 17 billion) · The
Nov 28, 2024
news.cision.com
Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs)
LA JOLLA, Calif.--(BUSINESS WIRE)---- $LBPH #Epilepsy--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it has initiated its global Phase 3 DEEp OCEAN Study evaluating its investigational drug bexicaserin for the treatment of seizures associated with Developmental and Epileptic Encephalopathies (DEEs) in participants two years of age and older. “The init
Nov 12, 2024
www.businesswire.com
Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
LA JOLLA, Calif.--(BUSINESS WIRE)---- $LBPH #Epilepsy--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today provided a corporate update and reported third quarter 2024 financial results. RECENT UPDATES: In October, announced an agreement for H. Lundbeck A/S (Lundbeck) to acquire Longboard in a strategic deal Bexicaserin (LP352), an oral, centrally acting, 5-HT2C superagoni
Nov 7, 2024
www.businesswire.com
Lundbeck's Neuro-Rare Pipeline Lands Cornerstone Drug via $2.6B Longboard Pharma Acquisition
Oct 15, 2024
medcitynews.com
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Longboard Pharmaceuticals, Inc.
NEW YORK, Oct. 14, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) and its board of directors concerning the proposed acquisition of the company by H. Lundbeck A/S. Stockholders will receive $60.00...
Oct 14, 2024
www.prnewswire.com

Top Companies in United States

Frequently Asked Questions Regarding Longboard Pharmaceuticals

Where is Longboard Pharmaceuticals located?

Longboard Pharmaceuticals's headquarters are located at 4275 Executive Sq Ste 950, La Jolla, California, 92037, United States

What is Longboard Pharmaceuticals's phone number?

Longboard Pharmaceuticals's phone number is (858) 789-9283

What is Longboard Pharmaceuticals's stock symbol?

Longboard Pharmaceuticals's stock symbol is LBPH

What is Longboard Pharmaceuticals's official website?

Longboard Pharmaceuticals's official website is www.longboardpharma.com

What is Longboard Pharmaceuticals's Revenue?

Longboard Pharmaceuticals's revenue is $10.6 Million

What is Longboard Pharmaceuticals's SIC code?

Longboard Pharmaceuticals's SIC: 87,873

What is Longboard Pharmaceuticals's NAICS code?

Longboard Pharmaceuticals's NAICS: 54,541

How many employees does Longboard Pharmaceuticals have?

Longboard Pharmaceuticals has 50 employees

What industry does Longboard Pharmaceuticals belong to?

Longboard Pharmaceuticals is in the industry of: Business Services General, Business Services

What is Longboard Pharmaceuticals competition?

Longboard Pharmaceuticals top competitors include: CANbridge Pharmaceuticals, Orphan Star Therapeutics, La Jolla Pharmaceutical, True North Therapeutics

What companies has Longboard Pharmaceuticals acquired?

Longboard Pharmaceuticals has acquired the companies: Synaptic Pharmaceutical, Elaiapharm, Chelsea Therapeutics International, Alder BioPharmaceuticals

What technology does Longboard Pharmaceuticals use?

Some of the popular technologies that Longboard Pharmaceuticals uses are: WordPress.org, Drupal, reCAPTCHA, PHP

Who is the CEO of Longboard Pharmaceuticals?

Longboard Pharmaceuticals's CEO is Kevin Lind

How do I contact Longboard Pharmaceuticals?

Longboard Pharmaceuticals contact info: Phone number: (858) 789-9283 Website: www.longboardpharma.com

What does Longboard Pharmaceuticals do?

What are Longboard Pharmaceuticals social media links?

Longboard Pharmaceuticals Linkedin page Longboard Pharmaceuticals Twitter page

Is Longboard Pharmaceuticals a public company?

Yes, Longboard Pharmaceuticals is a public company and is traded under the symbol LBPH

See more information about Longboard Pharmaceuticals

Longboard Pharmaceuticals Latest Hires and Their Positions

Longboard Pharmaceuticals is expanding and recently hired new employees. Here are the latest additions to the team.

Daniel Pontoriero

Director, Data Management

Joined Aug 1, 2024

Phone

Linh Truong

Clinical Operations Intern

Joined Jun 1, 2024

Phone

Jenna Hannon

Clinical Research Associate

Joined Jun 1, 2024

Phone

Michaela Scannell

Clinical Trial Assistant

Joined Jun 1, 2024

Phone

Sell Smarter. Win Faster.

Level up your game to ZoomInfo Copilot, intuitive AI that turns your data and high-quality ZoomInfo data into an unfair advantage for your go-to-market teams.